Literature DB >> 11118021

Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells.

A J Jenkins1, V Velarde, R L Klein, K C Joyce, K D Phillips, R K Mayfield, T J Lyons, A A Jaffa.   

Abstract

Glycation and/or oxidation of LDL may promote diabetic nephropathy. The mitogen-activated protein kinase (MAPK) cascade, which includes extracellular signal-regulated protein kinases (ERKs), modulates cell function. Therefore, we examined the effects of LDL on ERK phosphorylation in cultured rat mesangial cells. In cells exposed to 100 microg/ml native LDL or LDL modified by glycation, and/or mild or marked (copper-mediated) oxidation, ERK activation peaked at 5 min. Five minutes of exposure to 10-100 microg/ml native or modified LDL produced a concentration-dependent (up to sevenfold) increase in ERK activity. Also, 10 microg/ml native LDL and mildly modified LDL (glycated and/or mildly oxidized) produced significantly greater ERK activation than that induced by copper-oxidized LDL +/- glycation (P < 0.05). Pretreatment of cells with Src kinase and MAPK kinase inhibitors blocked ERK activation by 50-80% (P < 0.05). Native and mildly modified LDL, which are recognized by the native LDL receptor, induced a transient spike of intracellular calcium. Copper-oxidized (+/- glycation) LDL, recognized by the scavenger receptor, induced a sustained rise in intracellular calcium. The intracellular calcium chelator (EGTA/AM) further increased ERK activation by native and mildly modified LDL (P < 0.05). These findings demonstrate that native and modified LDL activate ERKs 1 and 2, an early mitogenic signal, in mesangial cells and provide evidence for a potential link between modified LDL and the development of glomerular injury in diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118021     DOI: 10.2337/diabetes.49.12.2160

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes.

Authors:  J L Barth; Y Yu; W Song; K Lu; A Dashti; Y Huang; W S Argraves; T J Lyons
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

2.  Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.

Authors:  Hesham M El-Shewy; Mimi Sohn; Parker Wilson; Mi Hye Lee; Samar M Hammad; Louis M Luttrell; Ayad A Jaffa
Journal:  Mol Endocrinol       Date:  2012-03-15

3.  Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy.

Authors:  D Fu; M Wu; J Zhang; M Du; S Yang; S M Hammad; K Wilson; J Chen; T J Lyons
Journal:  Diabetologia       Date:  2012-08-31       Impact factor: 10.122

4.  Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A).

Authors:  K Nakajou; S Horiuchi; M Sakai; N Haraguchi; M Tanaka; M Takeya; M Otagiri
Journal:  Diabetologia       Date:  2005-01-15       Impact factor: 10.122

5.  Diabetic LDL inhibits cell-cycle progression via STAT5B and p21(waf).

Authors:  Maria Felice Brizzi; Patrizia Dentelli; Marzia Pavan; Arturo Rosso; Roberto Gambino; Maria Grazia De Cesaris; Giovanni Garbarino; Giovanni Camussi; Gianfranco Pagano; Luigi Pegoraro
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

6.  Oxidative and endoplasmic reticulum stresses mediate apoptosis induced by modified LDL in human retinal Müller cells.

Authors:  Mingyuan Wu; Shihe Yang; Michael H Elliott; Dongxu Fu; Kenneth Wilson; Jing Zhang; Mei Du; Junping Chen; Timothy Lyons
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-09       Impact factor: 4.799

7.  Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients.

Authors:  P Nivoit; N Wiernsperger; P Moulin; M Lagarde; C Renaudin
Journal:  Diabetologia       Date:  2003-10-24       Impact factor: 10.122

8.  Antiproliferative effect of fluvastatin and thiazolidinedione in mesangial cells of diabetic rats.

Authors:  Mitsuru Okada; Hidehiko Yanagida; Hiroaki Kuwajima; Tsukasa Takemura
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

9.  Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy?

Authors:  M Du; M Wu; D Fu; S Yang; J Chen; K Wilson; T J Lyons
Journal:  Diabetologia       Date:  2013-07-11       Impact factor: 10.122

10.  Activation of protease calpain by oxidized and glycated LDL increases the degradation of endothelial nitric oxide synthase.

Authors:  Yunzhou Dong; Yong Wu; Mingyuan Wu; Shuangxi Wang; Junhua Zhang; Zhonglin Xie; Jian Xu; Ping Song; Kenneth Wilson; Zhengxing Zhao; Timothy Lyons; Ming-Hui Zou
Journal:  J Cell Mol Med       Date:  2008-06-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.